Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To assess the effect of multiple doses of mirabegron to postmenopausal adult female subjects
on the pharmacokinetics (PK) of tolterodine and its metabolites.
In addition, the safety of these products will be assessed.